Cochlear Limited Medical Equipment Company Share Analysis

Product Code GMD15214
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 62
ISBN Number not applicable
Change currency
PDF £630.00 €759 $996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Cochlear Limited Medical Equipment Company Share Analysis

Cochlear Limited Medical Equipment Company Share Analysis

Summary

This report is an essential source for data, analysis and strategic insight into Cochlear Limited. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

  • Revenues for the markets and sub-sectors Cochlear Limited operates in by country and region.
  • Detailed breakdowns of revenues and market share benchmarked against competitors.
  • Profiles of the pipeline of products that the company is developing.
  • Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
  • Provides summary analysis of key revenue lines and strategy.
  • Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
  • Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Research your competitors business structure, strategy and prospects.
  • Counter your competitors strengths and target their weaknesses.
  • Identify your competitors key revenue streams by market and geography.
  • Identify and assess potential corporate and investment opportunities
  • Support sales activities by understanding your customers businesses better.
  • Identify potential competitor products before they reach market.
  • Qualify prospective partners and suppliers.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What is this report about
    • 2.2 Definitions
      • 2.2.1 ENT Devices
        • 2.2.1.1 Hearing Implants
  • 3 Company Snapshot
    • 3.1 Key Information
    • 3.2 Company Overview
    • 3.3 Financial Performance
    • 3.4 SWOT Snapshot
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Implantable hearing devices
      • 4.2.1 Overview
      • 4.2.2 Financials
      • 4.2.3 Market View
      • 4.2.4 Key Strategies
    • 4.3 Major Products and Services
      • 4.3.1 Overview
  • 5 History
  • 6 Business Strategy
    • 6.1 Mission Statement
    • 6.2 Strategy
  • 7 Value Chain Analysis
    • 7.1 Manufacturing
      • 7.1.1 In House Manufacturing
    • 7.2 Product Development
      • 7.2.1 Regulatory Approvals
      • 7.2.2 Clinical Trials
      • 7.2.3 Research and Development
    • 7.3 Sales and Marketing
      • 7.3.1 Partnerships and Alliances
      • 7.3.2 Licensing Agreements
      • 7.3.3 E-distribution
  • 8 SWOT Analysis
    • 8.1 Overview
    • 8.2 Cochlear Limited Strengths
      • 8.2.1 Consistent revenue growth
      • 8.2.2 High returns
      • 8.2.3 Worldwide existence
    • 8.3 Cochlear Limited Weaknesses
      • 8.3.1 Lower turnover ratios
    • 8.4 Cochlear Limited Opportunities
      • 8.4.1 Acquisitions
      • 8.4.2 High profile industry meetings
      • 8.4.3 2007 DHL Australian Exporter of the Year
    • 8.5 Cochlear Limited Threats
      • 8.5.1 Technological developments
      • 8.5.2 Changes in reimbursement policies
  • 9 Competitors
  • 10 Cochlear Limited Medical Equipment Market share Analysis
    • 10.1 Cochlear limited, Global, Market Share (2006)
    • 10.2 Cochlear limited, APAC, Market Share (2006)
    • 10.3 Cochlear limited, Europe, Market Share (2006)
    • 10.4 Cochlear limited, MEA, Market Share (2006)
    • 10.5 Cochlear limited, North America, Market Share (2006)
    • 10.6 Cochlear limited, SCA, Market Share (2006)
  • 11 Revenue Analysis
    • 11.1 Revenue by Segment
    • 11.2 Revenue by Geography
  • 12 Financial and Operational Review
    • 12.1 Financial Statements
    • 12.2 Financial Ratios
  • 13 Share Holding Structure
  • 14 Key Employees
  • 15 Key Employee Biographies
  • 16 Locations And Subsidiaries
    • 16.1 Head Office
    • 16.2 Other Locations & Subsidiaries
  • 17 Financial Deals Landscape
    • 17.1 Private Equity
      • 17.1.1 Investor Growth Capital and Capman Exit Entific
    • 17.2 Acquisition
      • 17.2.1 Cochlear Acquires Entific From Nobel Biocare, CapMan And Investor Growth Capital
  • 18 Recent Developments
    • 18.1 Financial Announcements
      • 18.1.1 Aug 12, 2008: Cochlear Reports Fiscal 2008 Results
      • 18.1.2 Aug 14, 2007: Cochlear Declares Final Dividend
      • 18.1.3 Aug 14, 2007: Cochlear Reports Fiscal 2007 Results
      • 18.1.4 Feb 13, 2007: Cochlear Reports H1 Fiscal 2007 Results
      • 18.1.5 Aug 15, 2006: Cochlear Reports Fiscal 2006 Results
    • 18.2 Corporate Communications
      • 18.2.1 Dec 15, 2006: Cochlear Appoints New Board Member
      • 18.2.2 Jul 18, 2006: Cochlear Board Members To Retire
    • 18.3 Product News
      • 18.3.1 Jul 25, 2008: Cochlear Announces Milestone In Hearing Restoration With 120,000 Nucleus Cochlear Implants
  • 19 Appendix
    • 19.1 Global Markets Direct Research Methodology
    • 19.2 Coverage
    • 19.3 Secondary Research
    • 19.4 Primary Research
    • 19.5 Models
    • 19.6 Forecasts
    • 19.7 Expert Panels
    • 19.8 Market Revenue Chapters
      • 19.8.1 Abbreviations
      • 19.8.2 Currency Conversions
    • 19.9 About Global Markets Direct
    • 19.10 Contact Us
    • 19.11 Disclaimer
  • 1.1 List of Tables
    • Table 1: Cochlear Limited,Key Facts, 2007
    • Table 2: Cochlear Limited, SWOT Analysis, 2007
    • Table 3: Cochlear Limited, ENT Devices by Category, Global, Revenue ($ mn) and Market Share (%), 2006
    • Table 4: Cochlear Limited, ENT Devices by category, APAC, Revenue ($ mn) and Market Share (%), 2006
    • Table 5: Cochlear Limited, ENT Devices by category, Australia, Revenue ($ mn) and Market Share (%), 2006
    • Table 6: Cochlear Limited, ENT Devices by category, China, Revenue ($ mn) and Market Share (%), 2006
    • Table 7: Cochlear Limited, ENT Devices by category, India, Revenue ($ mn) and Market Share (%), 2006
    • Table 8: Cochlear Limited, ENT Devices by category, Japan, Revenue ($ mn) and Market Share (%), 2006
    • Table 9: Cochlear Limited, ENT Devices by category, New Zealand, Revenue ($ mn) and Market Share (%), 2006
    • Table 10: Cochlear Limited, ENT Devices by category, Republic of Korea, Revenue ($ mn) and Market Share (%), 2006
    • Table 11: Cochlear Limited, ENT Devices by category, Taiwan, Revenue ($ mn) and Market Share (%), 2006
    • Table 12: Cochlear Limited, ENT Devices by category, Europe, Revenue ($ mn) and Market Share (%), 2006
    • Table 13: Cochlear Limited, ENT Devices by category, Austria, Revenue ($ mn) and Market Share (%), 2006
    • Table 14: Cochlear Limited, ENT Devices by category, Belgium, Revenue ($ mn) and Market Share (%), 2006
    • Table 15: Cochlear Limited, ENT Devices by category, Czech Republic, Revenue ($ mn) and Market Share (%), 2006
    • Table 16: Cochlear Limited, ENT Devices by category, Finland, Revenue ($ mn) and Market Share (%), 2006
    • Table 17: Cochlear Limited, ENT Devices by category, France, Revenue ($ mn) and Market Share (%), 2006
    • Table 18: Cochlear Limited, ENT Devices, Germany, Revenue ($ mn) and Market Share (%), 2006
    • Table 19: Cochlear Limited, ENT Devices by category, Greece, Revenue ($ mn) and Market Share (%), 2006
    • Table 20: Cochlear Limited, ENT Devices by category, Hungary, Revenue ($ mn) and Market Share (%), 2006
    • Table 21: Cochlear Limited, ENT Devices by category, Ireland, Revenue ($ mn) and Market Share (%), 2006
    • Table 22: Cochlear Limited, ENT Devices by category, Italy, Revenue ($ mn) and Market Share (%), 2006
    • Table 23: Cochlear Limited, ENT Devices by category, Netherlands, Revenue ($ mn) and Market Share (%), 2006
    • Table 24: Cochlear Limited, ENT Devices by category, Norway, Revenue ($ mn) and Market Share (%), 2006
    • Table 25: Cochlear Limited, ENT Devices by category, Poland, Revenue ($ mn) and Market Share (%), 2006
    • Table 26: Cochlear Limited, ENT Devices by category, Portugal, Revenue ($ mn) and Market Share (%), 2006
    • Table 27: Cochlear Limited, ENT Devices by category, Russia, Revenue ($ mn) and Market Share (%), 2006
    • Table 28: Cochlear Limited, ENT Devices by category, Spain, Revenue ($ mn) and Market Share (%), 2006
    • Table 29: Cochlear Limited, ENT Devices by category, Sweden, Revenue ($ mn) and Market Share (%), 2006
    • Table 30: Cochlear Limited, ENT Devices by category, Switzerland, Revenue ($ mn) and Market Share (%), 2006
    • Table 31: Cochlear Limited, ENT Devices by category, Turkey, Revenue ($ mn) and Market Share (%), 2006
    • Table 32: Cochlear Limited, ENT Devices by category, United Kingdom, Revenue ($ mn) and Market Share (%), 2006
    • Table 33: Cochlear Limited, ENT Devices by category, MEA, Revenue ($ mn) and Market Share (%), 2006
    • Table 34: Cochlear Limited, ENT Devices by category, Egypt, Revenue ($ mn) and Market Share (%), 2006
    • Table 35: Cochlear Limited, ENT Devices by category, Israel, Revenue ($ mn) and Market Share (%), 2006
    • Table 36: Cochlear Limited, ENT Devices by category, South Africa, Revenue ($ mn) and Market Share (%), 2006
    • Table 37: Cochlear Limited, ENT Devices by category, UAE, Revenue ($ mn) and Market Share (%), 2006
    • Table 38: Cochlear Limited, ENT Devices by category, North America, Revenue ($ mn) and Market Share (%), 2006
    • Table 39: Cochlear Limited, ENT Devices by category, Canada, Revenue ($ mn) and Market Share (%), 2006
    • Table 40: Cochlear Limited, ENT Devices by category, USA, Revenue ($ mn) and Market Share (%), 2006
    • Table 41: Cochlear Limited, ENT Devices by category, SCA, Revenue ($ mn) and Market Share (%), 2006
    • Table 42: Cochlear Limited, ENT Devices by category, Argentina, Revenue ($ mn) and Market Share (%), 2006
    • Table 43: Cochlear Limited, ENT Devices by category, Brazil, Revenue ($ mn) and Market Share (%), 2006
    • Table 44: Cochlear Limited, ENT Devices by category, Chile, Revenue ($ mn) and Market Share (%), 2006
    • Table 45: Cochlear Limited, ENT Devices by category, Mexico, Revenue ($ mn) and Market Share (%), 2006
    • Table 46: Cochlear Limited, Revenue by Segment, A$ Thousand, 2003-2007
    • Table 47: Cochlear Limited, Revenue by Geography, A$ Thousand, 2003-2007
    • Table 48: Cochlear Limited, Financial Statements, A$ Thousand, 2003-2007
    • Table 49: Cochlear Limited, Financial Ratios, A$ Thousand, 2003-2007
    • Table 50: Cochlear Limited, Share Holding Structure
    • Table 51: Cochlear Limited, Key Employees, 2007
    • Table 52: Cochlear Limited, Subsidiaries
    • Table 53: Abbreviations used in the Market Revenue Chapters
    • Table 54: Currency Conversion used in the Market Revenue Chapters
  • 1.2 List of Figures
    • Figure 1: Cochlear Limited, Value Chain Analysis
    • Figure 2: Cochlear Limited, ENT Devices by Category, Global, Share of Market (%), 2006
    • Figure 3: Cochlear Limited, ENT Devices by Category, APAC, Share of Market (%), 2006
    • Figure 4: Cochlear Limited, ENT Devices by Category, Europe, Share of Market (%), 2006
    • Figure 5: Cochlear Limited, ENT Devices by Category, MEA, Share of Market (%), 2006
    • Figure 6: Cochlear Limited, ENT Devices by Category, North America, Share of Market (%), 2006
    • Figure 7: Cochlear Limited, ENT Devices by Category, SCA, Share of Market (%), 2006
    • Figure 8: Global Markets Direct Methodology